Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT02869867
Eligibility Criteria:
Inclusion Criteria:
* Major
* Do not opposing the participation in the study
* Monitoring in the case of localized neuropathic pain
* Diagnostic with neuropathic pain score ≥ 4
* Neuropathic pain conventional treatment failure of first-line
* Front advantage of laying a first patch Qutenza®
* With ability to understand the proposed study
Exclusion Criteria:
* Patch Installation on the feet, face, mucous membranes
* Eutectic mixture of local anesthetics (EMLA) Pose premedication
* Having Already received prior to the installation of a patch of Qutenza®
* Allergy to components Qutenza®
* Known and poorly stabilized hypertension
* Known cryoglobulinaemia
* Pregnant or lactating women
* Patient enjoying a measure of legal protection (guardianship, guardianship ...)
* Private Patient freedom
* No affiliation to a social security scheme.
* Refusal to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02869867
Study Brief:
Protocol Section:
NCT02869867